致编辑的信：回应Chin等人所著的《儿童移植冠状动脉疾病的预防：阿托伐他汀》 - Suppr

Suppr

超能文献

Letter to editor in response to "Prevention of pediatric graft coronary artery disease: atorvastatin", by Chin et al.

作者信息

Collins R Thomas, Hanna Brian, Shaddy Robert E

出版信息

Pediatr Transplant. 2009 Feb;13(1):141. doi: 10.1111/j.1399-3046.2008.01051.x.

DOI:10.1111/j.1399-3046.2008.01051.x

PMID:19172670

Abstract

摘要

相似文献

Letter to editor in response to "Prevention of pediatric graft coronary artery disease: atorvastatin", by Chin et al.

Pediatr Transplant. 2009 Feb;13(1):141. doi: 10.1111/j.1399-3046.2008.01051.x.

Statins, regulatory T cells, and pediatric graft coronary artery disease.

Pediatr Transplant. 2009 Feb;13(1):139-40. doi: 10.1111/j.1399-3046.2008.00995.x. Epub 2008 Jun 18.

Prevention of pediatric graft coronary artery disease: atorvastatin.

Pediatr Transplant. 2008 Jun;12(4):442-6. doi: 10.1111/j.1399-3046.2007.00827.x.

Atorvastatin and fibrinogen--a small subgroup shows extreme response.

Atherosclerosis. 1999 Aug;145(2):415-7. doi: 10.1016/s0021-9150(99)00072-6.

Efficacy and safety of atorvastatin after pediatric heart transplantation.

J Heart Lung Transplant. 2002 Nov;21(11):1213-7. doi: 10.1016/s1053-2498(02)00455-2.

Statins to prevent cardiovascular events in hypertensive patients. The ASCOT-LLA study.

Nephrol Dial Transplant. 2004 Mar;19(3):528-31. doi: 10.1093/ndt/gfg538.

Profound regression of coronary atherosclerosis with statins.

Can J Cardiol. 2006 Jun;22(8):709. doi: 10.1016/s0828-282x(06)70941-2.

Torcetrapib and atorvastatin.

N Engl J Med. 2005 Oct 6;353(14):1527-9; author reply 1527-9. doi: 10.1056/NEJMc055277.

[First comparison of 2 statins shows: only radical LDL lowering stops coronary atherosclerosis].

MMW Fortschr Med. 2003 Dec 18;145(51-52):38.

Qualitative plaque stabilization but not quantitative plaque regression.

Circ J. 2012;76(4):809-11. doi: 10.1253/circj.cj-12-0288.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Letter to editor in response to "Prevention of pediatric graft coronary artery disease: atorvastatin", by Chin et al.

Pediatr Transplant. 2009 Feb;13(1):141. doi: 10.1111/j.1399-3046.2008.01051.x.

Statins, regulatory T cells, and pediatric graft coronary artery disease.

Pediatr Transplant. 2009 Feb;13(1):139-40. doi: 10.1111/j.1399-3046.2008.00995.x. Epub 2008 Jun 18.

Prevention of pediatric graft coronary artery disease: atorvastatin.

Pediatr Transplant. 2008 Jun;12(4):442-6. doi: 10.1111/j.1399-3046.2007.00827.x.

Atorvastatin and fibrinogen--a small subgroup shows extreme response.

Atherosclerosis. 1999 Aug;145(2):415-7. doi: 10.1016/s0021-9150(99)00072-6.

Efficacy and safety of atorvastatin after pediatric heart transplantation.

J Heart Lung Transplant. 2002 Nov;21(11):1213-7. doi: 10.1016/s1053-2498(02)00455-2.

Statins to prevent cardiovascular events in hypertensive patients. The ASCOT-LLA study.

Nephrol Dial Transplant. 2004 Mar;19(3):528-31. doi: 10.1093/ndt/gfg538.

Profound regression of coronary atherosclerosis with statins.

Can J Cardiol. 2006 Jun;22(8):709. doi: 10.1016/s0828-282x(06)70941-2.

Torcetrapib and atorvastatin.

N Engl J Med. 2005 Oct 6;353(14):1527-9; author reply 1527-9. doi: 10.1056/NEJMc055277.

[First comparison of 2 statins shows: only radical LDL lowering stops coronary atherosclerosis].

MMW Fortschr Med. 2003 Dec 18;145(51-52):38.

Qualitative plaque stabilization but not quantitative plaque regression.

Circ J. 2012;76(4):809-11. doi: 10.1253/circj.cj-12-0288.